Cupping vs UVB: Comparable Psoriasis Outcomes? - Summary - MDSpire
From the Journals

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.

Share

In a small randomized controlled trial, sliding cupping therapy demonstrated comparable short-term benefits to narrowband ultraviolet B (NBUVB) phototherapy for patients with plaque psoriasis. Sixty participants received either treatment thrice weekly for eight weeks, showing significant reductions in Psoriasis Area and Severity Index (PASI) scores—62% in the cupping group and 67% in the NBUVB group. While both therapies presented similar improvements in clinical outcomes and mild adverse effects, further large-scale research is necessary to validate these findings and assess the long-term impact of cupping on psoriasis treatment.

Original Source(s)

Cupping vs UVB: Comparable Psoriasis Outcomes?

  • by Meg Barbor

  • April 9, 2026

Related Content

Forensic Dermatology and the CSI Effect

Media portrayals of forensic skin evidence create unrealistic jury expectations—and dermatologists testifying in court may need strategies to address them

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18

UVB and Psoriasis: More Than Immunosuppression

UVB's benefits may run deeper than inflammation suppression—cholesterol metabolism could be a key link.